Cargando…

The Performance of the Abbott Real Time MTB RIF/INH Compared to the MTBDRplus V2 for the Identification of MDR-TB Among Isolates

BACKGROUND: The GenoType MTBDRplus V2 line-probe assay (LPA) is routinely used in clinical patient management to characterise the susceptibility of Mycobacterium tuberculosis complex to rifampicin (Rif) and isoniazid (INH) directly from sputum and cultured isolates. The laboratory workflow requires...

Descripción completa

Detalles Bibliográficos
Autores principales:	David, Anura, Singh, Lyndel, Da Silva, Pedro, Scott, Lesley, Stevens, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532077/ https://www.ncbi.nlm.nih.gov/pubmed/33061477 http://dx.doi.org/10.2147/IDR.S247524

Ejemplares similares

Performance of the Abbott RealTime MTB and RIF/INH resistance assays for the detection of Mycobacterium Tuberculosis and resistance markers in sputum specimens
por: Araya, Bezalem Tesfaye, et al.
Publicado: (2021)

Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh
por: Kostera, Joshua, et al.
Publicado: (2018)

Combination of Xpert MTB/RIF and MTBDRplus for Diagnosing Tuberculosis in a Chinese District
por: Lv, Chunfang, et al.
Publicado: (2020)

Evaluation of the Roche cobas MTB and MTB-RIF/INH Assays in Samples from Germany and Sierra Leone
por: Nadarajan, Darshaalini, et al.
Publicado: (2021)

Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis
por: Ruiz, Pilar, et al.
Publicado: (2017)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Genotype(®)MTBDRplus and Xpert(®)MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis: cost analysis in a tertiary referral hospital
por: Soares, Valéria Martins, et al.
Publicado: (2020)

Retrospective diagnosis of lymphatic tuberculosis in frozen samples using two genetic amplification methods, Xpert® MTB/RIF ULTRA and Abbott RealTime MTB Assay
por: Fernandez-Pittol, Mariana, et al.
Publicado: (2021)

Rapid Screening of MDR-TB in Cases of Extra Pulmonary Tuberculosis Using Geno Type MTBDRplus
por: Kumari, Richa, et al.
Publicado: (2016)

Contribution of Xpert(®) MTB/RIF to pediatric TB diagnosis in Mozambique
por: Mutemba, C. M., et al.
Publicado: (2023)

A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB
por: Beutler, Markus, et al.
Publicado: (2020)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
por: Ershova, Julia V., et al.
Publicado: (2020)

Validation of the GenoType(® )MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand
por: Anek-vorapong, Rapeepun, et al.
Publicado: (2010)

Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis
por: Rahman, Arfatur, et al.
Publicado: (2016)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIV
por: Saavedra, Belén, et al.
Publicado: (2021)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Performance of Xpert(®) MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Evaluation of Xpert MTB/RIF Assay, MTB Culture and Line Probe Assay for the Detection of MDR Tuberculosis in AFB Smear Negative Specimens
por: Lama, Chandri, et al.
Publicado: (2022)

The Use of Xpert MTB/Rif for Active Case Finding among TB Contacts in North West Province, South Africa
por: Lebina, Limakatso, et al.
Publicado: (2016)

Estimating the effect of a rifampicin resistant tuberculosis diagnosis by the Xpert MTB/RIF assay on two-year mortality
por: De Vos, Elise, et al.
Publicado: (2023)

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study
por: Havumaki, Joshua, et al.
Publicado: (2017)

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
por: Mansfield, Mary, et al.
Publicado: (2022)

Diagnosis of paediatric TB using Xpert(®) MTB/RIF Ultra on fresh respiratory samples
por: Sabi, I., et al.
Publicado: (2022)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa
por: Hanrahan, Colleen F., et al.
Publicado: (2013)

Multi-Fluorescence Real-Time PCR Assay for Detection of RIF and INH Resistance of M. tuberculosis
por: Peng, Jingfu, et al.
Publicado: (2016)

The effect of the Xpert MTB/RIF test on the time to MDR-TB treatment initiation in a rural setting: a cohort study in South Africa’s Eastern Cape Province
por: Iruedo, Joshua, et al.
Publicado: (2017)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples
por: Meaza, Abyot, et al.
Publicado: (2017)

Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil
por: Pereira, Giovana Rodrigues, et al.
Publicado: (2018)

The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by Xpert MTB/RIF and smear
por: Zimba, Onani, et al.
Publicado: (2019)

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
por: Ponnudurai, Nirros, et al.
Publicado: (2018)

Upfront Xpert MTB/RIF for diagnosis of pediatric TB—Does it work? Experience from India
por: Kalra, Aakshi, et al.
Publicado: (2020)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB
por: Al-Mutairi, Noura M., et al.
Publicado: (2022)

Role of Xpert MTB/RIF in Bronchoalveolar lavage fluid of sputum-scarce, suspected Pulmonary TB patients
por: Kilaru, Satish Chandra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p8fp5d23sl6omu7rcv53h7c4uf